{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:47:24Z","timestamp":1788410844742,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003099","name":"FAZIT Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lo 274\/10-2"],"award-info":[{"award-number":["Lo 274\/10-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.expneurol.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:47:06Z","timestamp":1410828426000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy"],"prefix":"10.1016","volume":"263","author":[{"given":"Sabine","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2014.09.004_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-1211(98)00092-8","article-title":"The course of untreated seizures in the pilocarpine model of epilepsy","volume":"34","author":"Arida","year":"1999","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2011.12.014","article-title":"Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy","volume":"234","author":"Bankstahl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0015","first-page":"487","article-title":"Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions","volume":"19","author":"Borowicz","year":"2012","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0020","first-page":"83","article-title":"Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice","volume":"58","author":"Borowicz","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0025","first-page":"1082","article-title":"Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression","volume":"17","author":"Bukhari","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2013.11.020","article-title":"Chronic antidepressant treatment accelerates kindling epileptogenesis in rats","volume":"63","author":"Cardamone","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0035","series-title":"What's Wrong with My Mouse: Behavioral Phenotyping of Transgenic and Knockout Mice","author":"Crawley","year":"2007"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(97)01412-X","article-title":"Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant","volume":"340","author":"D'Aquila","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0045","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/0269881109349840","article-title":"Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood\u2013brain barrier: an experimental PET study in rats","volume":"24","author":"De Klerk","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0050","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/S1461145709009894","article-title":"Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood\u2013brain barrier","volume":"12","author":"De Klerk","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","article-title":"The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the mdr1a\/1b knockout mouse model","volume":"33","author":"Doran","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00787-013-0395-9","article-title":"Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study","volume":"22","author":"Dorks","year":"2013","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0065","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","author":"Dsm-Iv","year":"1994"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00146","article-title":"Mechanisms of antidepressant resistance","volume":"4","author":"El Hage","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pbb.2011.08.001","article-title":"Chronic agomelatine and fluoxetine induce antidepressant-like effects in H\/Rouen mice, a genetic mouse model of depression","volume":"100","author":"El Yacoubi","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bcp.2012.08.016","article-title":"Rhythm and blues: animal models of epilepsy and depression comorbidity","volume":"85","author":"Epps","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0085","first-page":"12","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","volume":"2012","author":"Garcia","year":"2012","journal-title":"Epilepsy Res. Treat."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1528-1157.2002.18101.x","article-title":"Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy","volume":"43","author":"Glien","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Gr\u00f6ticke","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.expneurol.2008.04.036","article-title":"Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate","volume":"213","author":"Gr\u00f6ticke","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0019-5545.105503","article-title":"IPS multicentric study: antidepressant prescription patterns","volume":"55","author":"Grover","year":"2013","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/pds.3649","article-title":"Trends in antidepressant prescriptions for children and adolescents in Germany from 2005 to 2012","author":"Hoffmann","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0115","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/epi.12406","article-title":"Shape features of epileptic spikes are a marker of epileptogenesis in mice","volume":"54","author":"Huneau","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.eplepsyres.2012.03.019","article-title":"The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events","volume":"101","author":"Igelstrom","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.expneurol.2007.09.026","article-title":"Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation","volume":"209","author":"Jones","year":"2008","journal-title":"Exp. Neurol."},{"issue":"Supplement 4","key":"10.1016\/j.expneurol.2014.09.004_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2003.10.004","article-title":"Depression in epilepsy: a frequently neglected multifaceted disorder","volume":"4","author":"Kanner","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-3223(03)00469-4","article-title":"Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment","volume":"54","author":"Kanner","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","article-title":"Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence","volume":"24","author":"Kanner","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0155","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.exger.2012.04.010","article-title":"Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL\/6 mice: implications for modeling elderly depression","volume":"47","author":"Malatynska","year":"2012","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1\u03b2 biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yebeh.2007.02.001","article-title":"Kindling epileptogenesis in immature rats leads to persistent depressive behavior","volume":"10","author":"Mazarati","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0170","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/brain\/awn117","article-title":"Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine","volume":"131","author":"Mazarati","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.11.001","article-title":"Comorbidity between epilepsy and depression: role of hippocampal interleukin-1\u03b2","volume":"37","author":"Mazarati","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.expneurol.2012.08.022","article-title":"Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization","volume":"238","author":"Mazzuferi","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02246218","article-title":"Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine","volume":"117","author":"Monleon","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0190","doi-asserted-by":"crossref","first-page":"e85617","DOI":"10.1371\/journal.pone.0085617","article-title":"Unique behavioral characteristics and microRNA signatures in a drug resistant epilepsy model","volume":"9","author":"Moon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2009.07.020","article-title":"Pilocarpine vs. lithium\u2013pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage","volume":"619","author":"M\u00fcller","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0200","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.expneurol.2009.05.035","article-title":"Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL\/6 mice","volume":"219","author":"M\u00fcller","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0205","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression","volume":"68","author":"Nemeroff","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0210","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1476-5381.2012.01858.x","article-title":"Inhibition of P-glycoprotein enhances transport of imipramine across the blood\u2013brain barrier: microdialysis studies in conscious freely moving rats","volume":"166","author":"O'Brien","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood\u2013brain barrier: clinical significance of in vitro and in vivo findings","volume":"165","author":"O'Brien","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0220","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2004.11.025","article-title":"Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice","volume":"1033","author":"Pericic","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13311-012-0110-4","article-title":"Interleukin-1beta causes fluoxetine resistance in an animal model of epilepsy-associated depression","volume":"9","author":"Pineda","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2012.09.015","article-title":"The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats","volume":"103","author":"Rattka","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yebeh.2013.05.002","article-title":"Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures","volume":"28","author":"Russo","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2012.09.019","article-title":"mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy","volume":"69","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0255","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"Neurobiology of depression as a comorbidity of epilepsy","author":"Sankar","year":"2012"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0260","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FPC.0b013e32833b593a","article-title":"ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression","volume":"20","author":"Sarginson","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-4328(03)00090-1","article-title":"Depressive-like behavioral alterations and c-fos expression in the dopaminergic brain regions in WAG\/Rij rats with genetic absence epilepsy","volume":"144","author":"Sarkisova","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yebeh.2010.12.021","article-title":"Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy","volume":"20","author":"Tchekalarova","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.09.004_bb0280","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1590\/S0004-282X2013000300011","article-title":"Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences","volume":"71","author":"Valente","year":"2013","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.expneurol.2014.09.004_bb0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00441-013-1664-0","article-title":"Chronic mild stress for modeling anhedonia","volume":"354","author":"Wiborg","year":"2013","journal-title":"Cell Tissue Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614002878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614002878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:13:07Z","timestamp":1772100787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488614002878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":57,"alternative-id":["S0014488614002878"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.09.004","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}